Difference between revisions of "Part:BBa K5271003"

 
(One intermediate revision by the same user not shown)
Line 24: Line 24:
  
 
::https://static.igem.wiki/teams/5271/dry/picture-7.png  
 
::https://static.igem.wiki/teams/5271/dry/picture-7.png  
::Figure 1. '''(a)''' 3D and 2D visualizations of molecular docking between the HER2 binding region of Panobody -scrambled the HER2 receptor. '''(Ba)''' 3D and 2D visualizations of molecular docking between the EGFR binding region of Panobody -scrambled and the EGFR receptor.
+
::Figure 1. '''(a)''' 3D and 2D visualizations of molecular docking between the HER2 binding region of Panobody -scrambled the HER2 receptor. '''(b)''' 3D and 2D visualizations of molecular docking between the EGFR binding region of Panobody -scrambled and the EGFR receptor.
  
  
Line 44: Line 44:
 
<!-- -->
 
<!-- -->
 
<span class='h3bb'>Sequence and Features</span>
 
<span class='h3bb'>Sequence and Features</span>
<partinfo>BBa_K5271002 SequenceAndFeatures</partinfo>
+
<partinfo>BBa_K5271003 SequenceAndFeatures</partinfo>
  
  
 
<!-- Uncomment this to enable Functional Parameter display  
 
<!-- Uncomment this to enable Functional Parameter display  
 
===Functional Parameters===
 
===Functional Parameters===
<partinfo>BBa_K5271002 parameters</partinfo>
+
<partinfo>BBa_K5271003 parameters</partinfo>
 
<!-- -->
 
<!-- -->

Latest revision as of 09:08, 29 September 2024


HER2-binding peptide -scrambled

A scrambled amino acid sequence that acts as a control for the HER2 binding region of the dual targeting nanobody -Panobody.


Profile

  • Name: HER2-binding peptide -scrambled
  • Base Pairs: 345 bp
  • Amino acid: 115 a.a
  • Origin: Synthetic
  • Properties: A scrambled control for the dual targeting nanobody -Panobody.


Usage and Biology

The design of this basic part began with an in-house bioinformatics analysis. Based on the dry lab result, we chose EGFR and HER2 as the dual targets for our Biobrick design. We created a dual targeting nanobody -Panobody for EGFR and HER2. To verify our design, we used Alphafold to create a three-dimensional model of Panobody and its scrambled control, Panobody-scrambled. [Jumper et al., 2021] Subsequently, we perform a molecular docking analysis to examine the binding affinity of the scrambled control.



The molecular docking analysis of Panobody- scrambled revealed a less extensive and intricate binding network. The scrambled HER2 binding region of Panobody- scrambled interacts with significant residues of the HER2 receptor, such as Lys765, Thr759, and Ash838, forming key hydrogen bonds and salt bridges and π-π stacking interactions, with Tyr835 playing a stabilizing role (Fig. 1a). However, the overall interaction network was less comprehensive than that observed for the Panobody.


picture-7.png
Figure 1. (a) 3D and 2D visualizations of molecular docking between the HER2 binding region of Panobody -scrambled the HER2 receptor. (b) 3D and 2D visualizations of molecular docking between the EGFR binding region of Panobody -scrambled and the EGFR receptor.


Design Note

Our preliminary results when it is joined with the EGFR nanobody by a linker, the linker should avoid cysteine residues since it potentially reduces the solubility of the dual targeting nanobody in prokaryotic expression system.


Source

The sequence of the HER2-binding peptide -scrambled was randomly generated and had a same length with the HER2 binding region of Panobody.


Reference

  • Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., ... & Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. nature, 596(7873), 583-589.



Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]